Tower Research Capital LLC (Trc) Eiger Bio Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.21 - $0.43 $374 - $767	1,785 Added 10.82%	18,278 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.93 $180 - $597	643 Added 4.06%	16,493 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $1.26 $349 - $800	-635 Reduced 3.85%	15,850 $11,000
Q1 2023 May 09, 2023	BUY	$0.89 - $2.52 $7,761 - $21,976	8,721 Added 112.33%	16,485 $15,000
Q4 2022 Feb 10, 2023	BUY	$1.02 - $7.48 $4,584 - $33,622	4,495 Added 137.5%	7,764 $9,000

Q3 2022 Nov 10, 2022	SELL	$6.04 - $9.66 $7,181 - $11,485	-1,189 Reduced 26.67%	3,269 $25,000
Q2 2022 Aug 15, 2022	SELL	$4.99 - $8.96 $12,185 - $21,880	-2,442 Reduced 35.39%	4,458 $28,000
Q1 2022 May 12, 2022	SELL	$3.84 - $9.74 $80,931 - $205,280	-21,076 Reduced 75.34%	6,900 $58,000
Q4 2021 Feb 14, 2022	BUY	$5.12 - $8.19 $6,876 - $10,999	1,343 Added 5.04%	27,976 $145,000
Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $163,339 - $222,513	24,452 Added 1121.14%	26,633 $178,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.23 $4,856 - $5,731	621 Added 39.81%	2,181 $19,000
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $4,025 - $6,038	-477 Reduced 23.42%	1,560 $14,000
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $145,746 - $224,464	-18,264 Reduced 89.97%	2,037 $25,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $130,209 - $203,166	16,358 Added 414.86%	20,301 $165,000
Q2 2020 Aug 13, 2020	BUY	$5.4 - $13.37 $20,989 - $51,969	3,887 Added 6941.07%	3,943 $37,000
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $274 - $823	56 New	56 $0
Q4 2019 Feb 07, 2020	SELL	$9.77 - $15.66 $5,236 - $8,393	-536 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$9.59 - $12.0 $41,802 - $52,308	-4,359 Reduced 89.05%	536 $5,000
Q2 2019 Aug 13, 2019	BUY	$9.54 - $14.96 $44,132 - $69,204	4,626 Added 1719.7%	4,895 $52,000
Q1 2019 May 14, 2019	SELL	$10.31 - $14.38 $31,136 - $43,427	-3,020 Reduced 91.82%	269 $4,000
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $14,144 - $20,323	1,639 Added 99.33%	3,289 $33,000
Q3 2018 Nov 13, 2018	BUY	$9.6 - $12.9 $13,507 - $18,150	1,407 Added 579.01%	1,650 $20,000
Q2 2018 Aug 15, 2018	BUY	$8.3 - $16.8 $2,016 - $4,082	243 New	243 $3,000
Q1 2018 May 15, 2018	SELL	$8.1 - $16.0 $45,222 - $89,328	-5,583 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$10.5 - $14.15 $58,621 - $78,999	5,583	5,583 $77,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $490M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account